Elanco Animal Health (ELAN) Cash from Financing Activities (2017 - 2026)

Elanco Animal Health has reported Cash from Financing Activities for 10 years, with the latest figure at -$65.0 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 225.0% year-over-year to -$65.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$392.0 million (up 72.26% YoY) and the FY2025 annual result came in at -$275.0 million, up 81.57% from the prior year.
• Cash from Financing Activities retreated to -$65.0 million in Q1 2026 per ELAN's latest filing, from -$18.0 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $174.0 million in Q1 2023 and troughed at -$1.3 billion in Q3 2024.
• A 5-year average of -$144.9 million and a median of -$93.0 million in 2024 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities slumped 10100.0% in 2022, then surged 292.59% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$84.0 million in 2022, then sank by 65.48% to -$139.0 million in 2023, then jumped by 76.98% to -$32.0 million in 2024, then jumped by 43.75% to -$18.0 million in 2025, then tumbled by 261.11% to -$65.0 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$65.0 million, -$18.0 million, and -$153.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.